Protagenic Therapeutics, Inc.new (PTIX) Operating Income (2009 - 2026)
Protagenic Therapeutics, Inc.new (PTIX) posted Operating Income of -$670,601 for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$1.11 million a year earlier.
Protagenic Therapeutics, Inc.new (PTIX) Operating Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Operating Income at Protagenic Therapeutics, Inc.new was -$2.68 million; for FY2026 (ended Mar 31, 2026), it was -$4.5 million.
- In prior fiscal years, Protagenic Therapeutics, Inc.new's Operating Income was -$2.59 million in FY2025, -$5.7 million in FY2024, -$4.53 million in FY2023 and -$3.56 million in FY2022.
- Quarterly Operating Income has run from a low of -$1.45 million in fiscal Q4 2025 to a high of -$120,331 in fiscal Q4 2026 over five years.
- According to Business Quant data, Operating Income for the three prior fiscal quarters was -$961,247 (Q1 2027), -$120,331 (Q4 2026) and -$925,103 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,293.04 Bn | 1,266.66 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 686.83 Bn | 606.69 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 525.76 Bn | 493.76 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.73 Bn | 325.68 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 313.98 Bn | 287.22 Bn | - | - |
| 6 | Astrazeneca | 287.17 Bn | 260.69 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 253.65 Bn | 205.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 210.81 Bn | 185.92 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.44 Bn | 112.80 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -3.51 Mn | - | -670,601.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -670,601.00 |
| Jun 30, 2026 | -961,247.00 |
| Mar 31, 2026 | -120,331.00 |
| Dec 31, 2025 | -925,103.00 |
| Sep 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.21 Mn |
| Mar 31, 2025 | -1.45 Mn |
| Dec 31, 2024 | -401,401.00 |
| Sep 30, 2024 | -355,374.00 |
| Jun 30, 2024 | -1.67 Mn |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | -1.21 Mn |
| Sep 30, 2023 | -1.43 Mn |
| Jun 30, 2023 | -1.14 Mn |
| Mar 31, 2023 | -739,294.00 |
| Dec 31, 2022 | -655,778.00 |
| Sep 30, 2022 | -924,060.00 |
| Jun 30, 2022 | -636,674.00 |
| Mar 31, 2022 | -1.34 Mn |
| Dec 31, 2021 | -861,219.00 |
Protagenic Therapeutics, Inc.new Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();